Bank of Montreal
CRMD icon

Bank of Montreal’s CorMedix CRMD Stock Holding History

Bank of Montreal’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-286,900
Closed -$1.22M – 3847
2022
Q4 		$1.22M Buy
286,900
+100,011
+54% +$354K ﹤0.01% 2071
2022
Q3 		$587 Sell
186,889
-94,711
-34% -$394K ﹤0.01% 2487
2022
Q2 		$1.02K Buy
+281,600
New +$1.05M ﹤0.01% 2287
2021
Q2 		– Sell
-1,261
Closed -$12K – 3930
2021
Q1 		$12K Sell
1,261
-4,045
-76% -$42.6K ﹤0.01% 4270
2020
Q4 		$44K Buy
5,306
+3,571
+206% +$24.3K ﹤0.01% 4013
2020
Q3 		$10K Sell
1,735
-637
-27% -$3.2K ﹤0.01% 4122
2020
Q2 		$15K Buy
2,372
+2,072
+691% +$9.59K ﹤0.01% 3973
2020
Q1 		$1K Sell
300
-2,861
-91% -$16.2K ﹤0.01% 3943
2019
Q4 		$23K Buy
3,161
+1,096
+53% +$6.7K ﹤0.01% 4237
2019
Q3 		$13K Buy
2,065
+98
+5% +$823 ﹤0.01% 4310
2019
Q2 		$18K Buy
+1,967
New +$15.4K ﹤0.01% 4233
2016
Q1 		– Sell
-163
Closed -$2K – 4213
2015
Q4 		$2K Buy
+163
New +$1.88K ﹤0.01% 3972

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return

Bank of Montreal's CRMD Position: Q1 2023 in Review

Bank of Montreal sold out of CorMedix (CRMD) in Q1 2023, closing a stake of 286,900 shares — an estimated $1.22M sold.

Bank of Montreal first reported a position in CRMD in Q4 2015 and held it in 12 quarters. The position peaked at $1.22M in Q4 2022. 65 funds tracked by Wall St. Rank hold CRMD as of Q1 2023.

  • Bank of Montreal reported no remaining CorMedix position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 286,900 CorMedix shares in Q1 2023, an estimated $1.22M.
  • Bank of Montreal first reported a position in CorMedix in Q4 2015 and held it in 12 quarters.
  • Bank of Montreal's CorMedix position peaked at $1.22M in Q4 2022.
  • 65 funds tracked by Wall St. Rank held CorMedix as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.